| TRIM16 |
|---|
| Tripartite Motif-Containing Protein 16 |
| Symbol | TRIM16 |
|---|
| Chromosome | 17p12 |
|---|
| NCBI Gene ID | 10678 |
|---|
| OMIM | 609678 |
|---|
| Ensembl ID | ENSG00000131865 |
|---|
| UniProt | Q9Y2H9 |
|---|
| Associated Diseases | ALS, Parkinson's Disease, Neuroblastoma |
|---|
TRIM16 (Tripartite Motif-containing 16) encodes a member of the TRIM (Tripartite Motif) family of proteins with E3 ubiquitin ligase activity. It is located on chromosome 17p12 and plays critical roles in autophagy regulation, oxidative stress response, and neuroprotection against protein aggregation in neurodegenerative diseases.
| Attribute |
Value |
| Symbol |
TRIM16 |
| Full Name |
Tripartite Motif-Containing Protein 16 |
| Chromosome |
17p12 |
| NCBI Gene ID |
10678 |
| OMIM |
609678 |
| Ensembl ID |
ENSG00000131865 |
| UniProt |
Q9Y2H9 |
| Protein Length |
640 amino acids |
TRIM16 possesses multiple functional domains that mediate its diverse cellular roles:
¶ Domain Structure
- RING finger: C3HC4 RING domain at N-terminus — mediates E3 ubiquitin ligase activity
- B-box domains: Two B-box motifs (B-box 1 and B-box 2) — involved in protein-protein interactions
- Coiled-coil region: Mediates homo- and heterodimerization with other TRIM proteins
TRIM16 functions as an E3 ubiquitin ligase that:
- Targets specific substrates for proteasomal degradation
- Catalyzes ubiquitin chain formation (K63-linked, K48-linked)
- Regulates protein turnover in cellular quality control
TRIM16 plays a major role in selective autophagy :
- Cargo recognition: Binds to ubiquitinated protein aggregates
- Autophagosome formation: Recruits autophagy machinery to aggregate-prone proteins
- Lysosomal delivery: Facilitates fusion with lysosomes
TRIM16 is activated by oxidative stress:
- Upstream sensors activate TRIM16 transcription under ROS conditions
- Protects neurons from oxidative damage
- Modulates antioxidant gene expression
TRIM16 protects against neurodegeneration through:
- Clearance of toxic protein aggregates
- Maintenance of proteostasis
- Anti-apoptotic signaling
TRIM16 mutations or dysregulation contribute to ALS pathogenesis:
- Dysregulated autophagy leads to accumulation of toxic protein aggregates
- Impaired clearance of TDP-43 inclusions (a hallmark of ALS)
- Motor neurons are particularly vulnerable
TRIM16 has protective effects against alpha-synuclein toxicity in Parkinson's disease :
- Aggregate clearance: TRIM16 promotes selective autophagy of alpha-synuclein aggregates
- Neuroprotection: Prevents dopaminergic neuron death under stress conditions
- Protein homeostasis: Maintains proteostasis in substantia nigra neurons
TRIM16 may have relevance to Alzheimer's disease:
TRIM16 has tumor suppressor functions:
- Acts as a transcriptional regulator
- Controls cell proliferation
- Induces apoptosis in cancer cells
- High expression: Brain (cortex, hippocampus, cerebellum), lung, testis
- Moderate expression: Spinal cord, heart, kidney
- Low expression: Liver, spleen, peripheral blood cells
- Cytoplasmic: Diffuse cytoplasmic distribution
- Organelle association: Endoplasmic reticulum, Golgi apparatus
- Aggregation sites: Colocalizes with protein aggregates in disease states
TRIM16 represents a potential therapeutic target:
- Autophagy enhancement: Small molecules that activate TRIM16 could enhance aggregate clearance
- Gene therapy: Viral vector delivery of TRIM16 to restore neuroprotection
- Combination therapy: TRIM16 activators combined with other autophagy modulators